Background. In populations pauci-immune to malaria, risk of severe malaria increases with age. This is particularly apparent in Plasmodium knowlesi malaria. However, pathophysiological mechanisms underlying knowlesi malaria, and of the age-related increase in risk of severe malaria in general, are poorly understood.
In regions highly endemic for malaria, severe malaria in adults is relatively uncommon due to acquisition of protective immunity. Thus, in sub-Saharan Africa where the great majority of deaths occur, nearly all due to Plasmodium falciparum, mortality has been largely confined to children aged <5 years [1] . In contrast, in nonimmune or partially immune populations, including in the increasing number of regions of unstable malaria endemicity [1] , severe falciparum malaria affects older children and adults [2, 3] . Moreover, the risk of severe falciparum malaria in these populations has been consistently shown to increase with age [3] [4] [5] [6] [7] . However, the mechanisms of this age-related increase in risk have not been evaluated.
In Plasmodium knowlesi malaria, an important emerging infection in Southeast Asia and the predominant cause of malaria in Malaysia [8, 9] , the effect of age on disease severity is particularly notable [2, 10] . In Malaysia, population immunity is presumed low with a reported annual parasite index of 0.08 [1] . In children, severe disease from P. knowlesi has not yet been reported, and in adults, severe disease predominantly affects the older age groups [2, 8] . Thus, P. knowlesi may represent an ideal model to evaluate the effects of aging on the pathogenic mechanisms that underlie severe adult malaria; in contrast to many infections, pathogen biomass can be readily quantified.
The pathogenesis of P. knowlesi malaria is not well understood. In falciparum malaria, the hallmark of severe disease is the endothelial cytoadherence of parasitized erythrocytes, leading to microvascular obstruction and tissue hypoxia [11] . Parasite biomass, endothelial activation, and microvascular dysfunction all contribute to poor outcomes [12, 13] . In knowlesi malaria, little is known about these pathogenic mechanisms. Endothelial cytoadherence may not be an important contributor to disease pathogenesis, based on a single human autopsy report [14] , the lack of specific malarial retinopathy [15] , the lack of any reported case of definite P. knowlesi-attributed coma, and a strong correlation between circulating parasitemia and disease severity [2] . However, the roles of inflammation, endothelial activation, and microvascular function in severe knowlesi malaria have not been evaluated. Furthermore, the independent effects of age on these processes, in P. knowlesi or indeed in any malaria species, have also not been investigated.
To understand the effects of aging on the pathogenic mechanisms of severe malaria, we measured factors known to be associated with severity in P. falciparum, including parasite biomass [16] , systemic inflammation [17] , endothelial activation [12] , and microvascular dysfunction [13] , and evaluated the independent effects of age in adults and children ≥12 years old with knowlesi and falciparum malaria. Healthy controls were included for comparison.
METHODS

Ethics Statement
The study was approved by the Ethics Committees of the Malaysian Ministry of Health and Menzies School of Health Research. Informed written consent was provided by all participating adults, and by the parent or guardian of any participant aged <18 years.
Study Site and Patients
Patients were enrolled as part of a prospective observational study of all malaria patients admitted to Queen Elizabeth Hospital, an adult tertiary-referral hospital in Sabah, Malaysia [2] . Consecutive patients with polymerase chain reaction (PCR)-confirmed knowlesi and falciparum monoinfection enrolled from September 2010 to October 2011 (nonsevere malaria) or November 2012 (severe malaria) were included if they were not pregnant, were ≥12 years old, had no major comorbidities or concurrent illness, and were within 18 hours of commencing antimalarial treatment. Severe malaria was defined as the presence of ≥1 of the following: unrousable coma (Glasgow Coma Scale score <11); multiple (>2) convulsions; respiratory distress (respiratory rate >30 breaths per minute and oxygen saturation <92%); hypotension (systolic blood pressure <80 mm Hg); jaundice (bilirubin >50 μmol/L plus parasitemia >100 000/µL [P. falciparum] or 20 000/µL [P. knowlesi] and/or creatinine >132 μmol/L); significant abnormal bleeding; hypoglycemia (blood glucose <2.2 mmol/L); metabolic acidosis (bicarbonate <15 mmol/L or lactate >4 mmol/L); acute kidney injury (creatinine >265 μmol/L); severe anemia (hemoglobin <7.5 g/dL); hyperparasitemia (>100 000/µL for P. knowlesi, or >500 000/µL for P. falciparum). Healthy controls were visitors or relatives of malaria patients, with no history of fever in the past 48 hours and with blood film negative for malaria parasites.
Standardized history and physical examination were documented. Hematology, biochemistry, acid-base parameters, and lactate (by bedside blood analysis; iSTAT system) were obtained on enrollment. Parasite counts were determined by microscopy, and parasite species were identified by PCR [18, 19] . Patients with severe disease were treated with intravenous artesunate, while those with nonsevere disease received oral artemisinin combination treatment, as previously described [2] .
Laboratory Assays
Venous blood collection in lithium heparin was centrifuged within 30 minutes of collection and plasma stored at -70°C. Plasma concentrations of the endothelial activation markers intercellular adhesion molecule 1 (ICAM-1), E-selectin, and angiopoietin-2 were measured using enzyme-linked immunosorbent assay (ELISA; R&D Systems). Interleukin (IL) 6 and IL-10 were measured by flow cytometry (BD Cytometric Bead Array). In falciparum malaria, parasite biomass was quantified by measuring histidine-rich protein 2 (HRP2) by ELISA [20] .
Microvascular Function
Microvascular function was assessed on enrollment using near infrared spectroscopy (NIRS; InSpectra 650, Hutchinson Technology, Hutchinson, Minnesota). NIRS uses a probe applied to the thenar eminence to noninvasively measure microcirculatory oxygenation (tissue oxygen saturation [StO 2 ]) before and after an ischemic stress, as previously described [13, 21] . To induce an ischemic stress, a vascular cuff was inflated to 200 mm Hg for 5 minutes and then rapidly deflated. Microvascular function was defined as the gradient of the StO 2 recovery slope from release of the vascular cuff until StO 2 had reached 85% of the baseline value. Measurement of microvascular function was discontinued on patients with nonsevere knowlesi and falciparum malaria in July 2011.
Statistical Analysis
Statistical analysis was performed with Stata software version 14 (StataCorp). For continuous variables, intergroup differences were compared using analysis of variance or Kruskal-Wallis tests depending on distribution. Student t test or Mann-Whitney test was used for 2-group comparisons. Categorical variables were compared using χ 2 test. Associations between continuous variables were assessed using Spearman's correlation coefficient (r s ). Partial correlation was used to evaluate associations between variables after adjusting for disease severity ± age and parasitemia, with nonnormally distributed variables log-transformed to normality. Backward stepwise regression was used to evaluate predictors of severe malaria, with variables removed at a significance level of >.05. For this analysis, and for analyses adjusting for disease severity, patients with hyperparasitemia as a sole severity criterion were reclassified as having nonsevere malaria.
RESULTS
Patients
A total of 276 patients and 50 controls were enrolled at an adult tertiary referral hospital. Malaria patients included 146 with knowlesi malaria (99 nonsevere, 47 severe) and 130 patients with falciparum malaria (109 nonsevere, 21 severe). The clinical and epidemiological features of a subset of these patients have been previously reported [2, 22, 23] . Baseline characteristics are shown in Table 1 . Seventy-four percent of patients with knowlesi malaria and 72% of those with falciparum malaria were male. Median age of patients with knowlesi malaria was 48 years (range, 13-83 years), compared to 27 years (range, 13-78 years) for patients with falciparum malaria (P < .0001). Median fever duration was 5 days, with no difference between knowlesi and falciparum malaria. There were no significant differences in the presenting features of patients with knowlesi or falciparum malaria. Although patients with knowlesi malaria were more likely to report having previously had malaria, compared to patients with falciparum malaria (28% vs 12%; P = .001), this did not remain significant after controlling for age (odds ratio [OR], 1.87; 95% confidence interval [CI], .94-3.75; P = .076). There was also no association between self-reported prior malaria and disease severity, for either knowlesi or falciparum malaria (Table 1) .
Among the 47 patients with severe knowlesi malaria, the most common severity criteria were hyperparasitemia (n = 24 Table 1 ). There were no significant differences in the severity criteria between patients with knowlesi and falciparum malaria, except for a higher proportion of patients with hyperparasitemia in knowlesi malaria. In patients with knowlesi malaria, 19 (40%) had 1 severity criterion, 17 (36%) had 2 criteria, and 11 (23%) had 3 or more criteria.
Coma occurred in 1 patient with falciparum malaria. No deaths occurred from either species. Seven patients (15%) with severe knowlesi malaria had hyperparasitemia (>100 000 parasites/ µL) as a single severity criterion. No patient with falciparum malaria had hyperparasitemia (>500 000 parasites/µL) as a single severity criterion.
Parasitemia and Age Independently Predict Severe P. knowlesi Malaria
Parasitemia was strongly associated with risk of severe disease in patients with knowlesi malaria, with median parasite count >7-fold higher in patients with severe compared to nonsevere knowlesi malaria (66 769 parasites/uL vs 9112 parasites/uL), after excluding hyperparasitemia as a severity criterion. Similarly, in falciparum malaria, HRP2, as a measure of parasite biomass, was 7-fold higher in severe compared to nonsevere disease ( Table 2) .
In knowlesi malaria, age was also strongly correlated with risk of severe disease, with severe disease occurring in 10 of 68 (15%), 18 of 44 (41%), and 19 of 34 (56%) patients aged 12-45 years, 46-60 years, and >60 years, respectively (P < .0001). This difference was less apparent in patients with falciparum malaria, with severe disease occurring in 16 of 111 (14%), 5 of 16 (31%), and 0 of 3 (0%) of patients in the same respective age groups (P = .196).
In knowlesi malaria, age was strongly correlated with parasitemia (r s = 0.36, P < .0001). Median parasite count was 4756 (interquartile range [IQR], 1589-24 963) parasites/µL in patients aged 12-45 years, 8925 (IQR, 3579-41 756) parasites/µL in patients aged 46-60 years, and 34 017 (IQR, 5300-123 590) parasites/µL in patients aged >60 years (P < .0001). In falciparum malaria, no correlation occurred between age and either parasitemia or HRP2. There was no association between age and fever duration in either species. After adjusting for age, there was also no association between parasitemia and self-reported malaria, in either species. Plasmodium knowlesi parasite counts parasites/µL; P = .002), with this difference remaining significant after controlling for age and fever duration (P < .0001). In a bivariate model including age and parasitemia, both factors predicted severe knowlesi malaria (age: OR, 1.03, P = .034; log parasite count: OR, 1.74, P < .0001; r 2 = 0.22), after excluding hyperparasitemia as a severity criterion. If the analysis was repeated with age as a categorical variable, the corresponding OR for age >45 years was 3.41 (95% CI, 1.37-8.50; P = .009). Using the same analysis for falciparum malaria (with age as either a continuous or categorical variable) only HRP2 predicted severe malaria (OR, 1.98 [95% CI, 1.41-2.78], P < .0001; r 2 = 0.19).
Inflammation and Endothelial Activation Are Increased in Severe
Knowlesi Malaria and Are Associated With Age IL-6, IL-10, and the IL-6/IL-10 ratio (as a measure of the balance between inflammatory and anti-inflammatory cytokines) were all increased in patients with knowlesi and falciparum malaria, in proportion to disease severity (Figure 1) , and in both species correlated with parasite biomass (Table 3) . In knowlesi malaria, but not falciparum malaria, IL-6 and the IL-6/IL-10 ratio correlated with age, after adjusting for parasitemia and disease severity (Table 4 ). In patients with knowlesi malaria, neutrophil count was also increased in severe compared to nonsevere disease. In both species, neutrophil count correlated with age, remaining significant after controlling for parasite biomass and disease severity in falciparum malaria.
Markers of endothelial activation (angiopoietin-2, ICAM-1, and E-selectin) were all increased in patients with knowlesi malaria, in proportion to disease severity and to a similar degree to that seen in falciparum malaria (Table 2) . Angiopoietin-2, ICAM-1, and E-selectin all correlated with parasitemia in knowlesi malaria, and with HRP2 in falciparum malaria, although the association between ICAM-1 and P. knowlesi parasitemia did not remain significant after controlling for disease severity (Table 3 ). In both knowlesi and falciparum malaria, angiopoietin-2 correlated with age, with these associations remaining significant after controlling for parasite biomass and disease severity (Table 4) . No correlation between endothelial activation markers and age occurred in healthy controls.
In patients with knowlesi and falciparum malaria, angiopoietin-2 correlated with creatinine, ICAM-1, E-selectin, and the IL-6/IL-10 ratio, and inversely with platelets, with these associations remaining significant after controlling for age, parasitemia/HRP2, and disease severity (Table 5) . In falciparum malaria, angiopoietin-2 also correlated independently with lactate, and in knowlesi malaria, with aspartate aminotransferase (as a marker of hepatic dysfunction).
In all patients with knowlesi malaria, IL-6, the IL-6/IL-10 ratio, and angiopoietin-2 were higher in those enrolled after, compared to before, commencing antimalarial treatment (Supplementary Table 2 ). However, the associations of angiopoietin-2, IL-6, and IL-6/IL-10 with age, parasitemia, and disease severity all remained significant after controlling for prior antimalarial treatment. In falciparum malaria, IL-6 and .024
Numbers are median (interquartile range). Significant differences between severe P. falciparum and severe P. knowlesi included age (P < .0001) and microvascular reactivity (P = .049).
Abbreviations: AST, aspartate aminotransferase; BDL, below detection limit; HRP2, histidine-rich protein 2; ICAM-1, intercellular adhesion molecule 1; IL, interleukin; NA, not assessed; NS, not significant (P > .05).
angiopoietin-2 did not differ significantly according to prior antimalarial treatment.
Microvascular Function Is Reduced in Severe Knowlesi Malaria, With the
Degree of Impairment Associated With Increasing Age
Microvascular function was decreased in patients with severe compared to nonsevere knowlesi malaria (median, 3.52 vs 6.07 units/second; P < .0001) and was lower in severe knowlesi compared to severe falciparum malaria (3.52 vs 4.88 units/second; P = .049) ( Table 1 ). In patients with knowlesi, but not falciparum malaria, microvascular function decreased with increasing age, after controlling for parasite biomass and disease severity (Table 4) . No correlation occurred between microvascular function and age in healthy controls. In patients with knowlesi malaria, after controlling for age, parasitemia, and disease severity, microvascular function was inversely correlated with IL-6 (P = .015), IL-6/IL-10 (P = .015), neutrophil count (P = .031), and lactate (P = .028).
There was no difference in microvascular function between patients enrolled before, or after, commencing antimalarial treatment. 
Predictors of Severe Malaria on Multivariate Analysis
In patients with knowlesi malaria, parasite count and angiopoietin-2 independently predicted severe malaria, after excluding hyperparasitemia as a severity criterion (Table 6) . In falciparum malaria, HRP2, angiopoietin-2, and microvascular dysfunction were all independent predictors of severe malaria.
DISCUSSION
In knowlesi malaria, age is strongly correlated with increasing parasitemia, and parasitemia predicts severe disease. In addition, we now show that in knowlesi malaria, increasing age is also associated with increasing systemic inflammation, increasing endothelial activation, and greater impairment of Univariate analysis was performed using Spearman correlation. Partial correlation was used to control for parasite biomass and disease severity, with all continuous variables log-transformed except age, and with hyperparasitemia excluded as a severity criterion.
Abbreviations: AST, aspartate aminotransferase; HRP2, histidine-rich protein 2; ICAM-1, intercellular adhesion molecule 1; IL, interleukin; NS, not significant (P > .05).
a Microvascular reactivity was measured in 99 patients with knowlesi malaria and 91 with falciparum malaria (Table 1) . microvascular function, independent of parasitemia. This suggests that aging exacerbates these processes, contributing to the increased severity of disease that occurs in older adults with P. knowlesi malaria. In falciparum malaria, endothelial activation is also associated with increasing age independent of parasite biomass, suggesting that as with P. knowlesi, this may contribute to differences in disease severity and manifestations that occur in older compared to younger patients with falciparum malaria [3] . The increase in disease severity and mortality with increasing age has been well-established in falciparum malaria. In the largest clinical trial ever performed in nonimmune or partially immune Southeast Asian children and adults with falciparum malaria, increasing age was associated with disease severity and increasing mortality [3] . Disease manifestations also differed according to age, with severe anemia and convulsions more common in the younger age groups, whereas jaundice, acute kidney injury, and hyperparasitemia were more common in the older age groups. The increase in mortality with increasing age occurred despite adjusting for differing disease presentations [3] . In another study involving Indonesian transmigrants moving to a region of high endemicity, nonimmune adults were 3-fold more likely than nonimmune children to be evacuated to hospital with malaria during the first 6 months of exposure to P. Multivariate analysis was performed using backward stepwise regression, with variables removed at a significance level of >.05. All variables were log-transformed except age. Hyperparasitemia was excluded as a severity criterion. Age cutoff values (45 years for knowlesi malaria and 30 years for falciparum malaria) were chosen to approximate the median age of patients with each species. Significant predictors of severe knowlesi and falciparum malaria, on univariate and multivariate analysis, remained unchanged if age was considered a continuous variable. Outcomes of the multivariate analyses also remained unchanged if IL-6/IL-10 ratio was included instead of IL-6.
Abbreviations: CI, confidence interval; HRP2, histidine-rich protein 2; IL, interleukin.
falciparum [5, 24] . Similarly, studies of adult and pediatric travelers returning to the United States [7] and Israel [6] and adult travelers returning to Europe [4] have demonstrated increasing P. falciparum fatality rates with increasing age. These age-related changes in pathogenesis and outcomes in malaria, in our study and in others, likely relate at least in part to age-related changes in the host immune response. An age-dependent increase in disease severity has been reported in a range of other infectious diseases, such as sepsis [25] , hepatitis A [26] , influenza [27] and West Nile virus (WNV) [28] , and an increasing body of evidence suggests that age-related changes in innate immunity play a fundamental role in these differing disease presentations [29] .
Numerous studies have demonstrated that aging is associated with a chronic increase in inflammation, sometimes referred to as "inflammaging" [30, 31] . Proinflammatory cytokines including C-reactive protein, IL-6, and tumor necrosis factor (TNF) are all increased in older adults, and have been shown to correlate with disability and mortality [26, [32] [33] [34] . The finding in our study of an independent association between age and IL-6 (and the IL-6/IL-10 ratio) in knowlesi malaria suggests that an age-dependent increase in inflammatory response may be an important contributor to the pathogenesis of severe malaria in older adults. This finding is consistent with studies involving mice with lipopolysaccharide-induced endotoxemia, demonstrating greater increases in IL-6 and TNF in aged vs young mice [35, 36] . Greater increases in inflammatory cytokines including IL-6 have also been demonstrated in WNVinfected macrophages from old vs young human donors, with this age-dependent alteration in the innate immune response hypothesized to contribute to permeability of the blood-brain barrier and the increased severity of WNV infection in older individuals [37] .
In our study, we also demonstrated an age-dependent increase in endothelial activation (as measured by angiopoietin-2), in both knowlesi and falciparum malaria. An association between angiopoietin-2 and age has been reported in population studies of humans without overt infection [38] , and in aged vs young mice, angiopoietin-2 has been shown to be increased both at baseline and following lipopolysaccharide-induced endotoxemia [39] . The importance of endothelial activation in the pathogenesis of severe falciparum malaria is well-described, with angiopoietin-2 consistently shown to be a risk factor for mortality, independent of parasite biomass [12, 40] . Similarly, in our study angiopoietin-2 was an independent risk factor for severe disease in both falciparum and knowlesi malaria.
We also demonstrated an association between age and impairment of microvascular function in knowlesi malaria. Although in our study microvascular function was not an independent risk factor for severe knowlesi malaria on multivariate analysis, the independent association with lactate suggests that microvascular dysfunction may contribute to impaired tissue perfusion and pathogenesis of organ dysfunction in severe knowlesi malaria.
While our study provides insights into the effects of aging on pathogenic mechanisms of severe malaria, the association between age and parasitemia in knowlesi malaria requires further investigation. Given the strong correlation between parasitemia and disease severity, this association is likely a major contributor to the age-related risk of severe knowlesi malaria. One possible explanation is that higher parasitemias may result from greater exposure to the mosquito vectors of P. knowlesi. Higher P. falciparum parasitemias have been reported in children during high vs low transmission seasons [41] , and in our study P. knowlesi parasitemia was significantly higher in farmers and plantation workers compared to other occupations, independent of age and duration of fever. However, exposure-dependent parasitemia does not appear to fully explain the pattern of parasite densities seen in the current study, with parasitemias substantially higher in adults >60 years old compared to those aged 45-60 years (median, 34 017 vs 11 716 parasites/uL). A more likely explanation is that age-related changes in immune function lead to a reduced ability of older adults to control parasitemia. As an example, γ-Δ T cells have been shown to contribute to elimination of Plasmodium parasites through production of interferon-γ and enhancement of dendritic cell activation [42, 43] , and impairment in the function of these cells with age has been described [44] . Further studies are required to further evaluate the effects of aging on the innate immune response to malaria infection in nonimmune individuals.
Our study had some limitations. First, this study was performed at an adult hospital, and our findings of factors associated with disease severity in knowlesi malaria may not be applicable to children <12 years. Furthermore, this may have limited our power to detect age-related differences, particularly in falciparum malaria. Second, a proportion of patients included in the study had commenced antimalarial treatment up to 18 hours prior to enrollment, and this may have affected some results, for example, concentrations of IL-6 and angiopoietin-2. However, the associations of IL-6 and angiopoietin-2 with age and disease severity all remained significant after controlling for prior antimalarial treatment. Finally, cytokine levels may have degraded during storage; however, this should not have affected between-group comparisons or associations with age.
In conclusion, we report that in knowlesi malaria, parasite biomass, inflammation, endothelial activation and microvascular function are all increased in severe disease and all likely contribute to its pathogenesis. Moreover, we found that in knowlesi malaria these processes were independently associated with increasing age, with endothelial activation also increasing with age in falciparum malaria. Our findings suggest that aging may play an important role in the host response to malaria, resulting in greater severity of disease in older adults. We speculate that this effect of aging may become more apparent as malaria transmission decreases across the malaria-endemic world, with median age of malaria patients increasing as transmission intensity and acquired protective immunity wanes. The effects of aging should be incorporated into future studies on the pathogenic mechanisms of severe malaria, while malaria control programs should monitor the changing demographics of malaria-affected populations, and related associations between age and disease severity.
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